Nasal COVID Treatment Shows Early Promise
The viral inhibitor also appears effective against all coronavirus variants of concern, neutralizing even the Omicron variants BA.5, XBB, and BQ.1.1 in laboratory and mice studies.
Source: medscape.com
Stay updated with breaking news from Potential First Line. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The viral inhibitor also appears effective against all coronavirus variants of concern, neutralizing even the Omicron variants BA.5, XBB, and BQ.1.1 in laboratory and mice studies.
An antiviral therapy in early development has the potential to prevent or treat COVID-19 infection when given as a nasal spray in as little as 4 hours before or after exposure.